nach oben

Supportive Care in Cancer

Erschienen in:

01.07.2015 | Review Article

Optimizing cancer care through mobile health

verfasst von: Bassel Odeh, Reem Kayyali, Shereen Nabhani-Gebara, Nada Philip

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

The survival rates for patients living with cancer are increasing, due to recent advances in detection, prevention and treatment. It has been estimated that there were 28 million cancer survivors around the world in 2012. In the UK, for patients diagnosed in 2007, it is predicted that more than half of them will survive their cancer for 5 years or more. A large majority of cancer survivors report unmet supportive care needs and distressing symptoms and adverse long-term consequences related to their cancer. Cancer management could be optimized to better meet patients demand through technology, including mobile health (m-Health). m-Health is defined as the use of mobile communications and network technologies for health care. m-Health can help both patients and health-care professionals and play an important part in managing and delivering cancer care including managing side effects, supporting drug adherence, providing cancer information, planning and follow up and detecting and diagnosing cancer. Health authorities have already published guidelines regulating m-Health to insure patient safety and improve the accountability of its applications.

American Cancer Society (2014) Cancer facts and statistics. American Cancer Society. http://www.cancer.org/research/cancerfactsstatistics/. Accessed 24 Mar 2014

Cancer Research UK (2014) Cancer survival statistics. Cancer Research UK. http://www.cancerresearchuk.org/cancer-info/cancerstats/survival/. Accessed 24 Mar 2014

Boyes AW, Girgis A, D’Este C, Zucca AC (2012) Prevalence and correlates of cancer survivors’ supportive care needs 6 months after diagnosis: a population-based cross-sectional study. BMC Cancer 12(1):150CrossRefPubMedCentralPubMed

Williamson S (2011) A report on the dispensing and supply of oral chemotherapy and systemic anticancer medicines in primary care. BOPA, RPS, NPA

Istepanian R, Laxminarayan S, Pattichis CS (2006) M-health: emerging mobile health systems. In: Istepanian R, Laxminarayan S, Pattichis CS (eds) 2006 XXX, 624 p 182 illus 0-387-26558-9 Berlin: Springer, 1

WHO (2010) mHealth new horizons for health through mobile technologies. Global observatory for eHealth series, vol 3. WHO, Geneva

ABI Research (2014) Q4 2013 Smartphone OS results: is Google losing control of the android ecosystem?

Sanou B (2013) The World in 2013: ICT facts and figures. International Telecommunications Union

Bender JL, Yue RYK, To MJ, Deacken L, Jadad AR (2013) A lot of action, but not in the right direction: systematic review and content analysis of smartphone applications for the prevention, detection, and management of cancer. J Med Internet Res 15(12)

10.

Klasnja P, Pratt W (2012) Healthcare in the pocket: mapping the space of mobile-phone health interventions. J Biomed Inform 45(1):184–198PubMedCentralPubMed

11.

Wangberg SC, Årsand E, Andersson N (2006) Diabetes education via mobile text messaging. J Telemed Telecare 12(suppl 1):55–56PubMed

12.

Chomutare T, Fernandez-Luque L, Årsand E, Hartvigsen G (2011) Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines. J Med Internet Res 13(3)

13.

Krishna S, Boren SA, Balas EA (2009) Healthcare via cell phones: a systematic review. Telemed e-Health 15(3):231–240

14.

Holtz B, Lauckner C (2012) Diabetes management via mobile phones: a systematic review. Telemed e-Health 18(3):175–184

15.

Scherr D, Zweiker R, Kollmann A, Kastner P, Schreier G, Fruhwald F (2006) Mobile phone-based surveillance of cardiac patients at home. J Telemed Telecare 12(5):255–261PubMed

16.

Rubel P, Fayn J, Nollo G, Assanelli D, Li B, Restier L, Adami S, Arod S, Atoui H, Ohlsson M (2005) Toward personal eHealth in cardiology. Results from the EPI-MEDICS telemedicine project. J Electrocardiol 38(4):100–106PubMed

17.

Rosser BA, Eccleston C (2011) Smartphone applications for pain management. J Telemed Telecare 17(6):308–312PubMed

18.

Pandey A, Hasan S, Dubey D, Sarangi S (2013) Smartphone apps as a source of cancer information: changing trends in health information-seeking behavior. J Cancer Educ 28(1):138–142PubMed

19.

Obermayer JL, Riley WT, Asif O, Jean-Mary J (2004) College smoking-cessation using cell phone text messaging. J Am Coll Health 53(2):71–78PubMed

20.

Haug S, Meyer C, Schorr G, Bauer S, John U (2009) Continuous individual support of smoking cessation using text messaging: a pilot experimental study. Nicotine Tob Res 11(8):915–923PubMed

21.

Fairhurst K, Sheikh A (2008) Texting appointment reminders to repeated non-attenders in primary care: randomised controlled study. Qual Saf Health Care 17(5):373–376PubMed

22.

Consolvo S, Klasnja P, McDonald DW, Avrahami D, Froehlich J, LeGrand L, Libby R, Mosher K, Landay JA (2008) Flowers or a robot army?: encouraging awareness & activity with personal, mobile displays. In: Proceedings of the 10th international conference on Ubiquitous computing. ACM, pp 54–63

23.

Department of Health (2007) The cancer reform strategy. London

24.

NHS Scotland (2007) Better health, better care: a discussion document. Scottish Executive, Edinburgh

25.

Dranitsaris G, Maroun J, Shah A (2005) Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea. Can J Gastroenterol 19(2):83–87PubMed

26.

Chen-Hardee S, Chrischilles EA, Voelker MD, Brooks JM, Scott S, Link BK, Delgado D (2006) Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin’s lymphoma (United States). Cancer Causes Control 17(5):647–654PubMed

27.

Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106(10):2258–2266CrossRefPubMed

28.

Coolbrandt A, Van den Heede K, Vanhove E, De Bom A, Milisen K, Wildiers H (2011) Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: does timing matter? Eur J Oncol Nurs 15(2):130–136PubMed

29.

Homsi J, Walsh D, Rivera N, Rybicki LA, Nelson KA, LeGrand SB, Davis M, Naughton M, Gvozdjan D, Pham H (2006) Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer 14(5):444–453PubMed

30.

Kayyali R, Nabhani-Gebara S, Olszewska A, Adeniyi M (2012) Investigation of bowel and breast cancer patients’ perception of counselling and written information provided regarding the oral chemotherapy agent capecitabine. Int J Pharm Pract 20(S2):85

31.

Nabhani-Gebara S, Kayyali R, Olszewska A (2013) Patient counselling—a dying art? Pharmacoepidemiol Drug Saf 22(6):684–685

32.

Nabhani-Gebara S, Kayyali R, Olszewska A (2012) Patients’ perception of educational material surrounding their cancer treatment. Eur J Oncol Nurs 16(S1):S30

33.

Weaver A, Young A, Rowntree J, Townsend N, Pearson S, Smith J, Gibson O, Cobern W, Larsen M, Tarassenko L (2007) Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol 18(11):1887–1892PubMed

34.

Maguire R, Miller M, Sage M, Norrie J, McCann L, Taylor L, Kearney N (2005) Results of a UK based pilot study of a mobile phone based advanced symptom management system (ASyMS) in the remote monitoring of chemotherapy related toxicity. Clin Eff Nurs 9(3):202–210

35.

Ghafoor S, Kayyali R, Nabhani-Gebara S, Sobnath D, Philip N (2013) Evaluating patients’ acceptability of alternative means of support for oral chemotherapy counselling and side effect management using a smartphone application. Int J Pharm Pract 21(2):27–28

36.

Maguire R, McCann L, Miller M, Kearney N (2008) Nurse’s perceptions and experiences of using of a mobile-phone-based Advanced Symptom Management System (ASyMS^©) to monitor and manage chemotherapy-related toxicity. Eur J Oncol Nurs 12(4):380–386PubMed

37.

Kearney N, McCann L, Norrie J, Taylor L, Gray P, McGee-Lennon M, Sage M, Miller M, Maguire R (2009) Evaluation of a mobile phone-based, advanced symptom management system (ASyMS©) in the management of chemotherapy-related toxicity. Support Care Cancer 17(4):437–444PubMed

38.

Gibson F, Aldiss S, Taylor RM, Maguire R, McCann L, Sage M, Kearney N (2010) Utilization of the Medical Research Council Evaluation Framework in the Development of Technology for Symptom Management: the ASyMS (c)-YG Study. Cancer Nurs 33(5):343–352PubMed

39.

Baggott C (2013) Patient-reported outcomes collected via smartphone: adolescent cancer patients’ nausea trajectories. Eur J Oncol Nurs 17(6):895

40.

Partridge AH, Avorn J, Wang PS, Winer EP (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94(9):652–661PubMed

41.

Partridge AH, Ades T, Spicer P, Englander L, Wickerham DL (2007) Helping breast cancer patients adhere to oral adjuvant hormonal therapy regimens. Commun Oncol 4(12):725–731

42.

Bedell CH (2003) A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents. Clin J Oncol Nurs 7:5–9PubMed

43.

Thompson AMDJ, Fahey T, McCowan C (2007) Association of poor adherence to prescribed tamoxifen with risk of death from breast cancer. In: American Society of Clinical Oncology Breast Cancer Symposium USA

44.

Ruddy K, Mayer E, Partridge A (2009) Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 59(1):56–66. doi:10.3322/caac.20004 PubMed

45.

Banna GL, Collova E, Gebbia V, Lipari H, Giuffrida P, Cavallaro S, Condorelli R, Buscarino C, Tralongo P, Ferrau F (2010) Anticancer oral therapy: emerging related issues. Cancer Treat Rev 36(8):595–605. doi:10.1016/j.ctrv.2010.04.005 PubMed

46.

Moore S (2007) Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs 30(2):112–122PubMed

47.

Decker V, Spoelstra S, Miezo E, Bremer R, You M, Given C, Given B (2009) A pilot study of an automated voice response system and nursing intervention to monitor adherence to oral chemotherapy agents. Cancer Nurs 32(6):E20–E29PubMed

48.

Becker S, Kribben A, Meister S, Diamantidis CJ, Unger N, Mitchell A (2013) User profiles of a smartphone application to support drug adherence—experiences from the iNephro project. PLoS One 8(10):e78547CrossRefPubMedCentralPubMed

49.

Smith TJ, Dow LA, Virago E, Khatcheressian J, Lyckholm LJ, Matsuyama R (2010) Giving honest information to patients with advanced cancer maintains hope. Oncology 24(6):521–525PubMed

50.

Smith TJ, Dow LA, Virago EA, Khatcheressian J, Matsuyama R, Lyckholm LJ (2011) A pilot trial of decision aids to give truthful prognostic and treatment information to chemotherapy patients with advanced cancer. J Support Oncol 9(2):79PubMedCentralPubMed

51.

Matsuyama RK, Wilson-Genderson M, Kuhn L, Moghanaki D, Vachhani H, Paasche-Orlow M (2011) Education level, not health literacy, associated with information needs for patients with cancer. Patient Educ Couns 85(3):e229–e236PubMed

52.

Dieng M, Trevena L, Turner RM, Wadolowski M, McCaffery K (2013) What Australian women want and when they want it: cervical screening testing preferences, decision‐making styles and information needs. Health Expect 16(2):177–188PubMed

53.

Mistry A, Wilson S, Priestman T, Damery S, Haque M (2010) How do the information needs of cancer patients differ at different stages of the cancer journey? A cross-sectional survey. JRSM Short Rep 1(4):30PubMedCentralPubMed

54.

Halkett GK, Kristjanson LJ, Lobb E, Little J, Shaw T, Taylor M, Spry N (2012) Information needs and preferences of women as they proceed through radiotherapy for breast cancer. Patient Educ Couns 86(3):396–404PubMed

55.

Güleser GN, Taşci S, Kaplan B (2012) The experience of symptoms and information needs of cancer patients undergoing radiotherapy. J Cancer Educ 27(1):46–53PubMed

56.

Klasnja P, Hartzler A, Powell C, Phan G, Pratt W (2010) Health weaver mobile: designing a mobile tool for managing personal health information during cancer care. In: AMIA Annual Symposium Proceedings. American Medical Informatics Association, p 392

57.

Payne KFB, Wharrad H, Watts K (2012) Smartphone and medical related App use among medical students and junior doctors in the United Kingdom (UK): a regional survey. BMC Med Inform Decis Mak 12(1):121PubMedCentralPubMed

58.

O’Neill S, Brady R (2012) Colorectal smartphone apps: opportunities and risks. Color Dis 14(9):e530–e534

59.

Bibault J-E, Leroy T, Blanchard P, Biau J, Cervellera M, Diaz O, Faivre JC, Fumagalli I, Lescut N, Martin V (2014) Mobile technology and social media in the clinical practice of young radiation oncologists: results of a comprehensive nationwide cross-sectional study. Int J Radiat Oncol* Biol* Phys

60.

Rozati H, Shah SP, Shah N (2014) Smartphone applications for the clinical oncologist in UK practice. J Cancer Educ 1–7

61.

Brennan ME, Butow P, Marven M, Spillane AJ, Boyle FM (2011) Survivorship care after breast cancer treatment—experiences and preferences of Australian women. Breast 20(3):271–277PubMed

62.

Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, Hantel A, Henry NL, Muss HB, Smith TJ (2013) Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(7):961–965PubMed

63.

Hall SJ, Samuel LM, Murchie P (2011) Toward shared care for people with cancer: developing the model with patients and GPs. Fam Pract 28(5):554–564PubMed

64.

Pascoe SW, Neal RD, Allgar VL, Selby PJ, Wright EP (2004) Psychosocial care for cancer patients in primary care? Recognition of opportunities for cancer care. Fam Pract 21(4):437–442PubMed

65.

Rozmovits L, Rose P, Ziebland S (2004) In the absence of evidence, who chooses? A qualitative study of patients’ needs after treatment for colorectal cancer. J Health Serv Res Policy 9(3):159–164PubMed

66.

Cox K, Wilson E, Heath L, Collier J, Jones L, Johnston I (2006) Preferences for follow-up after treatment for lung cancer: assessing the nurse-led option. Cancer Nurs 29(3):176–187PubMed

67.

Donnelly P, Hiller L, Bathers S, Bowden S, Coleman R (2007) Questioning specialists’ attitudes to breast cancer follow-up in primary care. Ann Oncol

68.

Okera M, Baker NA, Hayward A, Selva‐Nayagam S (2011) Oncology workforce issues: the challenge of the outpatient clinic. Intern Med J 41(6):499–503PubMed

69.

Green J, Murchie P, Lee AJ (2013) Does patients’ place of residence affect the type of physician performing primary excision of cutaneous melanoma in northern Scotland? J Rural Health 29(s1):s35–s42PubMed

70.

Dickinson R, Hall S, Sinclair JE, Bond C, Murchie P (2014) Using technology to deliver cancer follow-up: a systematic review. BMC Cancer 14(1):311CrossRefPubMedCentralPubMed

71.

Matthew AG, Currie KL, Irvine J, Ritvo P, Santa Mina D, Jamnicky L, Nam R, Trachtenberg J (2007) Serial personal digital assistant data capture of health-related quality of life: a randomized controlled trial in a prostate cancer clinic. Health Qual Life Outcomes 5:38PubMedCentralPubMed

72.

Ott J, Ullrich A, Miller A (2009) The importance of early symptom recognition in the context of early detection and cancer survival. Eur J Cancer 45(16):2743–2748PubMed

73.

Pontén J, Adami HO, Bergström R, Dillner J, Friberg LG, Gustafsson L, Miller AB, Parkin DM, Sparén P, Trichopoulos D (1995) Strategies for global control of cervical cancer. Int J Cancer 60(1):1–26PubMed

74.

Teppo L, Dickman PW, Hakulinen T, Luostarinen T, Pukkala E, Sankila R, Söderman B (1999) Cancer patient survival—patterns, comparisons, trends: a population-based cancer registry study in Finland. Acta Oncol 38(3):283–294PubMed

75.

Richards M, Westcombe A, Love S, Littlejohns P, Ramirez A (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353(9159):1119–1126PubMed

76.

Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106(3):416–422PubMed

77.

Vis AN, Roemeling S, Reedijk AM, Otto SJ, Schröder FH (2008) Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort. Eur Urol 53(1):91–98PubMed

78.

Wang J-H, Changchien C-S, Hu T-H, Lee C-M, Kee K-M, Lin C-Y, Chen C-L, Chen T-Y, Huang Y-J, Lu S-N (2008) The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma—survival analysis of 3892 patients. Eur J Cancer 44(7):1000–1006PubMed

79.

Horn L-C, Fischer U, Raptis G, Bilek K, Hentschel B (2007) Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 107(2):310–315PubMed

80.

Wolf JA, Moreau JF, Akilov O, Patton T, English JC, Ho J, Ferris LK (2013) Diagnostic inaccuracy of smartphone applications for melanoma detection. JAMA Dermatol 149(4):422–426PubMedCentralPubMed

81.

Maier T, Kulichova D, Schotten K, Astrid R, Ruzicka T, Berking C, Udrea A (2014) Accuracy of a smartphone application using fractal image analysis of pigmented moles compared to clinical diagnosis and histological result. J Eur Acad Dermatol Venereol

82.

Mobasheri MH, Johnston M, King D, Leff D, Thiruchelvam P, Darzi A (2014) Smartphone breast applications—what’s the evidence? Breast. doi:10.1016/j.breast.2014.07.006 PubMed

83.

Yuan C (2014) Mobile health in cancer care: a new solution or a potential risk? Cancer Nurs 37(2):83PubMed

84.

Agu E, Pedersen P, Strong D, Tulu B, He Q, Wang L, Li Y (2013) The smartphone as a medical device: assessing enablers, benefits and challenges. In: Internet-of-Things Networking and Control (IoT-NC), 2013 I.E. International Workshop of. IEEE, pp 48–52

85.

McCartney M (2013) How do we know whether medical apps work? BMJ: Br Med J 346

86.

Buijink AWG, Visser BJ, Marshall L (2012) Medical apps for smartphones: lack of evidence undermines quality and safety. Evidence Based Medicine:ebmed-2012-100885

87.

Medicines and Healthcare products Regulatory Agency (MHRA) (2014) Guidance on medical device stand-alone software (including apps). http://www.mhra.gov.uk/Howweregulate/Devices/Software/index.htm. Accessed 21 Aug 2014

88.

NHS Choices (2014) Health apps library. http://apps.nhs.uk/. Accessed 21 Aug 2014

89.

European Commission (2012) MEDDEV 2.1/6 -Guidelines on the qualification and classification of stand alone software used in healthcare within the regulatory framework of medical devices

90.

US Food and Drug Administration (2013) Mobile medical applications: guidance for Industry and Food and Drug Administration Staff

Titel: Optimizing cancer care through mobile health
verfasst von: Bassel Odeh
Reem Kayyali
Shereen Nabhani-Gebara
Nada Philip
Publikationsdatum: 01.07.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 7/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-015-2627-7

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

Optimizing cancer care through mobile health

Abstract

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2015

Participation in questionnaire studies among couples affected by breast cancer

Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction

Validation study of the EORTC information questionnaire (EORTC QLQ-INFO25) in Iranian cancer patients

Cancer-related fatigue: results from patient experience surveys undertaken in a UK regional cancer centre

Evaluation of the progression and treatment of experimental periodontitis in rats subjected to chemotherapy with 5-fluorouracil

Siblings of children with cancer—the price they pay to function

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie